Basar Kilic S, Erdal H
Medicine (Baltimore). 2025; 104(10):e41715.
PMID: 40068069
PMC: 11903012.
DOI: 10.1097/MD.0000000000041715.
Untaaveesup S, Kantagowit P, Ungprasert P, Kitlertbanchong N, Vajiraviroj T, Sutithavinkul T
J Clin Med. 2025; 14(4).
PMID: 40004904
PMC: 11855964.
DOI: 10.3390/jcm14041374.
Teo L, Juantuah-Kusi N, Subramanian G, Sampath P
Noncoding RNA. 2025; 11(1).
PMID: 39997616
PMC: 11858470.
DOI: 10.3390/ncrna11010016.
Nguyen C, Nguyen N, Van T
Clin Cosmet Investig Dermatol. 2025; 18:367-378.
PMID: 39968328
PMC: 11832437.
DOI: 10.2147/CCID.S502902.
Biscetti F, Polito G, Rando M, Nicolazzi M, Eraso L, DiMuzio P
Int J Mol Sci. 2025; 26(2).
PMID: 39859250
PMC: 11765428.
DOI: 10.3390/ijms26020535.
External validation of the accuracy of cardiovascular risk prediction tools in psoriatic disease: a UK Biobank study.
Hughes D, Yiu Z, Zhao S
Clin Rheumatol. 2025; 44(3):1151-1161.
PMID: 39833655
PMC: 11865138.
DOI: 10.1007/s10067-025-07325-y.
Association Between Statin Use and Psoriasis in Patients with Dyslipidemia: A Korean National Health Screening Cohort Study.
Han K, Kwon M, Choi H, Kim J, Kim J, Yoo D
J Clin Med. 2025; 14(1.
PMID: 39797174
PMC: 11721600.
DOI: 10.3390/jcm14010091.
Biologic therapy for psoriasis is associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD). A study on the association of cardiometabolic conditions with psoriasis treatment.
Armijo-Borjon G, Miranda-Aguirre A, Garza-Silva A, Fernandez-Chau I, Sanz-Sanchez M, Gonzalez-Cantu A
Arch Dermatol Res. 2025; 317(1):195.
PMID: 39775081
DOI: 10.1007/s00403-024-03688-5.
Updates on Psoriasis in Special Areas.
Butacu A, Toma C, Negulet I, Manole I, Banica A, Plesea A
J Clin Med. 2025; 13(24.
PMID: 39768472
PMC: 11728371.
DOI: 10.3390/jcm13247549.
Psoriasis and dementia: A population-based matched cohort study of adults in England.
Matthewman J, Mansfield K, Cadogan S, Abuabara K, Smith C, Bhaskaran K
Ann Clin Transl Neurol. 2025; 12(2):393-404.
PMID: 39743756
PMC: 11822786.
DOI: 10.1002/acn3.52283.
Treating adult patients of severe psoriasis with methotrexate leads to reduction in biomarkers of atherosclerosis: A prospective study.
Neema S, Vasudevan B, Misra P, Rai R, Sibin M, Vendhan S
Med J Armed Forces India. 2024; 80(Suppl 1):S174-S179.
PMID: 39734852
PMC: 11670649.
DOI: 10.1016/j.mjafi.2023.03.004.
Amygdalin alleviates psoriasis-like lesions by improving skin barrier function.
Wang Q, Zhang H, Wang X, Ma C, Zhang J, Wu J
Arch Dermatol Res. 2024; 317(1):115.
PMID: 39673560
DOI: 10.1007/s00403-024-03550-8.
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials.
Armstrong A, Lebwohl M, Warren R, Sofen H, Imafuku S, Ohtsuki M
JAMA Dermatol. 2024; 161(1):56-66.
PMID: 39602111
PMC: 11736510.
DOI: 10.1001/jamadermatol.2024.4688.
The FORWARD Psoriasis Registry: Patient-Reported Outcomes in a Novel Psoriasis Registry and Comparison of Traditional, Dermatologist-Led Enrollment With Web-Based Patient Enrollment.
Song W, Michaud K, Lonowski S, Kaufmann M, Pearson R, Del Rosso J
J Psoriasis Psoriatic Arthritis. 2024; :24755303241303089.
PMID: 39583218
PMC: 11581183.
DOI: 10.1177/24755303241303089.
Potentially traumatic events, posttraumatic stress symptoms, and skin-related quality of life among adults with self-reported skin disease symptoms.
Strange T, Clark H, Dixon L
Arch Dermatol Res. 2024; 317(1):19.
PMID: 39546010
PMC: 11568012.
DOI: 10.1007/s00403-024-03451-w.
Patient-Identified Treatment Goals for Psoriatic Disease: Results From a US Patient Survey.
Armstrong A, Levit N, Schneider B, Seiden R, Shi L, Kaplan B
J Psoriasis Psoriatic Arthritis. 2024; :24755303241290495.
PMID: 39544333
PMC: 11559564.
DOI: 10.1177/24755303241290495.
Cardiodermatology: the heart of the connection between the skin and cardiovascular disease.
Gelfand J, Song W, Langan S, Garshick M
Nat Rev Cardiol. 2024; .
PMID: 39537837
DOI: 10.1038/s41569-024-01097-9.
Laboratory and clinical haemostatic aberrations in primary dermatologic disease: A review.
Sharma D, Thomas S, Moody T, Taylor M, Ituarte B, Georgeson C
Thromb J. 2024; 22(1):101.
PMID: 39533305
PMC: 11558853.
DOI: 10.1186/s12959-024-00665-w.
A comparison of comorbidities and their risk factors prevalence across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis with focus on cardiovascular diseases: data from a single center real-world cohort.
Gula Z, Losinska K, Kuszmiersz P, Strach M, Nowakowski J, Biedron G
Rheumatol Int. 2024; 44(12):2817-2828.
PMID: 39527279
PMC: 11618134.
DOI: 10.1007/s00296-024-05740-z.
The prognostic impact of stress hyperglycemia ratio for all-cause mortality in patients with Psoriasis.
Tuersun G, Alifu J, Qu Y, Kang X
Sci Rep. 2024; 14(1):26113.
PMID: 39478002
PMC: 11525686.
DOI: 10.1038/s41598-024-77019-z.
